Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,622
Closed -$826K 160
2025
Q3
$826K Hold
27,622
0.01% 115
2025
Q2
$821K Sell
27,622
-33,452
-55% -$964K 0.01% 108
2025
Q1
$1.86M Hold
61,074
0.03% 106
2024
Q4
$2.42M Sell
61,074
-12,020
-16% -$467K 0.04% 97
2024
Q3
$2.83M Buy
+73,094
New +$2.96M 0.05% 105

Other funds holding SRDX

Carmignac Gestion's SRDX Position: Q4 2025 in Review

Carmignac Gestion sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 27,622 shares — an estimated $826K sold.

Carmignac Gestion first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $2.83M in Q3 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Carmignac Gestion reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Carmignac Gestion sold 27,622 Surmodics shares in Q4 2025, an estimated $826K.
  • Carmignac Gestion first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
  • Carmignac Gestion's Surmodics position peaked at $2.83M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Carmignac Gestion's 13F filing for Q4 2025, filed 13 Feb 2026.